Evaluation of Asymptomatic Contralateral Foot Deformities Using the Tripod Index.


Journal

The Iowa orthopaedic journal
ISSN: 1555-1377
Titre abrégé: Iowa Orthop J
Pays: United States
ID NLM: 8908272

Informations de publication

Date de publication:
2019
Historique:
entrez: 25 6 2020
pubmed: 1 1 2019
medline: 20 8 2020
Statut: ppublish

Résumé

The primary aim of this study was to determine the prevalence of asymptomatic pes planus and cavovarus foot deformities using the tripod index (TI). A retrospective study was conducted on 122 adult subjects over the age of 18 from January 2010 to December 2016 with symptomatic pes planus (n=78) or cavovarus (n=44) foot deformities. We subdivided both groups into subjects who presented with unilateral symptomatic deformities (pes planus unilateral symptomatic; cavovarus unilateral symptomatic) and bilateral symptomatic foot deformities (pes planus bilateral symptomatic feet and cavovarus bilateral symptomatic feet). The severity of TI was compared between sides. The prevalence of asymptomatic pes planus and cavovarus foot deformities was 52% and 67.6%, respectively. Subjects with unilateral symptomatic foot deformities had significantly more severe TI values for the symptomatic cavovarus foot -98.96% (-288.89 to 0%) compared to asymptomatic cavovarus -67.41% (-270.59 to 14.71%) (p=0.015). Subjects with unilateral symptomatic pes planus deformity also had more severe TI on the symptomatic foot 57.49 (-9.38 to 141.67%) compared to the asymptomatic foot 30.43 (-51.52 to 119.23%) (p<0.01). Subjects with bilateral symptomatic foot deformities had no significant difference in severity of Tripod Index between feet. Although half of subjects with unilateral symptomatic deformities had a foot deformity on the contralateral side, the severity of deformity between symptomatic and asymptomatic feet was significantly different for both pes planus and cavovarus feet. Further studies should prospectively follow postoperative radiographs to determine whether a correction in foot alignment directly improves symptoms.

Sections du résumé

Background
The primary aim of this study was to determine the prevalence of asymptomatic pes planus and cavovarus foot deformities using the tripod index (TI).
Methods
A retrospective study was conducted on 122 adult subjects over the age of 18 from January 2010 to December 2016 with symptomatic pes planus (n=78) or cavovarus (n=44) foot deformities. We subdivided both groups into subjects who presented with unilateral symptomatic deformities (pes planus unilateral symptomatic; cavovarus unilateral symptomatic) and bilateral symptomatic foot deformities (pes planus bilateral symptomatic feet and cavovarus bilateral symptomatic feet). The severity of TI was compared between sides.
Results
The prevalence of asymptomatic pes planus and cavovarus foot deformities was 52% and 67.6%, respectively. Subjects with unilateral symptomatic foot deformities had significantly more severe TI values for the symptomatic cavovarus foot -98.96% (-288.89 to 0%) compared to asymptomatic cavovarus -67.41% (-270.59 to 14.71%) (p=0.015). Subjects with unilateral symptomatic pes planus deformity also had more severe TI on the symptomatic foot 57.49 (-9.38 to 141.67%) compared to the asymptomatic foot 30.43 (-51.52 to 119.23%) (p<0.01). Subjects with bilateral symptomatic foot deformities had no significant difference in severity of Tripod Index between feet.
Conclusion
Although half of subjects with unilateral symptomatic deformities had a foot deformity on the contralateral side, the severity of deformity between symptomatic and asymptomatic feet was significantly different for both pes planus and cavovarus feet. Further studies should prospectively follow postoperative radiographs to determine whether a correction in foot alignment directly improves symptoms.

Identifiants

pubmed: 32577112
pmc: PMC7047301

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-84

Informations de copyright

Copyright © The Iowa Orthopaedic Journal 2019.

Déclaration de conflit d'intérêts

Disclosures: Phinit Phisitkul is a paid consultant for Arthrex and Restor 3D, receives royalties from Arthrex; and has stock/stock options in First Ray and Mortise Medical.

Références

J Pediatr Orthop. 2005 May-Jun;25(3):360-5
pubmed: 15832156
Foot Ankle Int. 2015 Sep;36(9):1006-16
pubmed: 25857939
Instr Course Lect. 2004;53:311-21
pubmed: 15116624
J Am Podiatr Med Assoc. 2013 Jan-Feb;103(1):16-23
pubmed: 23328848
Iowa Orthop J. 2013;33:47-53
pubmed: 24027460
Foot Ankle. 1993 Oct;14(8):476-86
pubmed: 8253442
Foot Ankle Int. 2013 Oct;34(10):1411-20
pubmed: 23657663
Foot Ankle Int. 2006 Jan;27(1):2-8
pubmed: 16442022
Ann Biomed Eng. 2014 Sep;42(9):1913-22
pubmed: 24920256
Foot Ankle Int. 2008 Aug;29(8):781-6
pubmed: 18752775
Clin Orthop Relat Res. 1999 Aug;(365):81-90
pubmed: 10627690
Foot Ankle Int. 1997 Feb;18(2):85-8
pubmed: 9043880
Instr Course Lect. 1997;46:393-405
pubmed: 9143981
J Bone Joint Surg Br. 1995 Mar;77(2):254-7
pubmed: 7706341
Foot Ankle Int. 1997 Nov;18(11):710-5
pubmed: 9391816
J Bone Joint Surg Am. 1986 Jan;68(1):95-102
pubmed: 3941124
Foot Ankle Int. 1998 Aug;19(8):520-4
pubmed: 9728698
J Surg Orthop Adv. 2010 Fall;19(3):166-9
pubmed: 21086930
Foot Ankle Int. 2004 May;25(5):318-21
pubmed: 15134612
Br Med J. 1963 Sep 14;2(5358):659-61
pubmed: 14044868
Foot Ankle Int. 2005 Mar;26(3):256-63
pubmed: 15766431
Iowa Orthop J. 2005;25:44-6
pubmed: 16089071
J Bone Joint Surg Am. 1969 Jun;51(4):759-64
pubmed: 5783853
Clin Orthop Relat Res. 1983 Dec;(181):37-45
pubmed: 6641065
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006154
pubmed: 17943889
J Bone Joint Surg Am. 2002 Nov;84(11):2005-9
pubmed: 12429762
J Am Acad Orthop Surg. 2014 Aug;22(8):512-20
pubmed: 25063749
Foot Ankle Int. 2009 Jul;30(7):604-12
pubmed: 19589305
J Pediatr Orthop. 2006 Jul-Aug;26(4):438-43
pubmed: 16791058
Clin Orthop Relat Res. 1989 Sep;(246):273-81
pubmed: 2766615
Foot Ankle Int. 2002 Jan;23(1):26-9
pubmed: 11822689
Curr Rev Musculoskelet Med. 2013 Dec;6(4):294-303
pubmed: 23765382

Auteurs

Courtney Carlson (C)

Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN USA.

Craig Akoh (C)

Department of Orthopedics and Rehabilitation, University of Wisconsin School of Medicine, Madison, WI USA.

Chamnanni Rungprai (C)

Phramongkutklao Hospital and College of Medicine, Thung Phaya Thai, Ratchathewi, Bangkok, Thailand.

Phinit Phisitkul (P)

University of Iowa Hospitals and Clinics, Department of Orthopedics and Rehabilitation. Iowa City, IA USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH